Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · IEX Real-Time Price · USD
52.66
+0.25 (0.48%)
At close: Jul 19, 2024, 4:00 PM
52.76
+0.10 (0.19%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Crinetics Pharmaceuticals Market Cap
Crinetics Pharmaceuticals has a market cap or net worth of $4.15 billion as of July 22, 2024. Its market cap has increased by 318.20% in one year.
Market Cap
4.15B
Enterprise Value
3.30B
1-Year Change
318.20%
Ranking
Category
Stock Price
$52.66
Market Cap Chart
Since July 18, 2018, Crinetics Pharmaceuticals's market cap has increased from $539.40M to $4.15B, an increase of 669.88%. That is a compound annual growth rate of 40.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 4.15B | 74.73% |
| Dec 29, 2023 | 2.38B | 141.36% |
| Dec 30, 2022 | 984.70M | -27.03% |
| Dec 31, 2021 | 1.35B | 190.53% |
| Dec 31, 2020 | 464.50M | -23.56% |
| Dec 31, 2019 | 607.70M | -15.70% |
| Dec 31, 2018 | 720.90M | 33.65% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Haemonetics | 4.52B |
| Avidity Biosciences | 4.32B |
| Inspire Medical Systems | 4.27B |
| Integer Holdings | 4.23B |
| Alkermes | 4.20B |
| Immunovant | 4.09B |
| Dyne Therapeutics | 4.06B |
| Axsome Therapeutics | 4.03B |